Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy.

Literature DB >> 21686791

Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy.

Alice Breining¹, Amelie Guihot, Dominique Warot, Ana Canestri, Gilles Peytavin, Francois Bricaire, Eric Caumes.

Abstract

Nevirapine is an antiretroviral agent associated with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Such a case in an immunocompetent woman recently treated with nevirapine for postexposure HIV prophylaxis is reported here. Despite a period of 12 days after interruption of treatment, a high blood level of nevirapine was still observed.

Entities: Chemical Disease Species

Year: 2009 PMID： 21686791 PMCID： PMC3027339 DOI： 10.1136/bcr.07.2008.0475

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

13 in total

1. DRESS syndrome associated with nevirapine therapy.

Authors: G A Claudio; A F Martin; S de Dios Perrino; A A Velasco
Journal: Arch Intern Med Date: 2001-11-12

2. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.

Authors: M Lanzafame; P Rovere; G De Checchi; M Trevenzoli; M Turazzini; A Parrinello
Journal: Scand J Infect Dis Date: 2001

Review 3. Nevirapine toxicity.

Authors: B O Taiwo
Journal: Int J STD AIDS Date: 2006-06 Impact factor: 1.359

4. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).

Authors: Katherine S Fields; Marta J Petersen; Elizabeth Chiao; Payam Tristani-Firouzi
Journal: J Drugs Dermatol Date: 2005 Jul-Aug Impact factor: 2.114

5. A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

Authors: Nils von Hentig; Amina Carlebach; Peter Gute; Gaby Knecht; Stefan Klauke; Maren Rohrbacher; Hartmut Stocker; Michael Kurowski; Sebastian Harder; Schlomo Staszewski; Annette Haberl
Journal: Br J Clin Pharmacol Date: 2006-11 Impact factor: 4.335

3. Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients.

Authors: David Brandariz; Alex Smithson; Vanesa Anton-Vazquez
Journal: Indian J Sex Transm Dis AIDS Date: 2017 Jul-Dec

3 in total

Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy.

1. DRESS syndrome associated with nevirapine therapy.

2. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.

Review 3. Nevirapine toxicity.

4. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).

5. A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

6. [Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients].

7. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Review 8. [Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)].

9. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients.

10. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.

1. Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV.

2. DRESS Syndrome due to Nevirapine Treated with Methylprednisolone.

3. Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients.